Just because a variant spreads faster, it doesn’t necessarily mean it has a higher R0.
L’expertise universitaire, l’exigence journalistique
Articles sur Epidemiology
Affichage de 21 à 40 de 201 articles
By late July 2022, monkeypox was present in more than 70 countries with significant spread in certain communities. As a result, the World Health Organization began taking steps to fight the virus.
The monkeypox virus, which is commonly found in West and Central Africa, is now causing many infections in the U.S., Europe and Latin America.
Our ability to use mathematical modelling is accelerating breakthrough discoveries in health care and biotechnology.
Allowing cats to roam unsupervised is detrimental to humans, wildlife and the cats themselves. Managing free-roaming cats should consider the risks they pose to other species.
The COVID-19 pandemic has seen an increase in wastewater testing to monitor the spread of the virus. But historical cases show that targeted surveillance can further marginalize vulnerable populations.
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
Monte Carlo simulations can predict different potential outcomes because they provide for the presence of random variables or elements.
People want a simple answer. Is this action safe? But despite Anthony Fauci bouncing responsibility for COVID-19 risk assessment to individuals, your risk can’t be boiled down to one probability.
The risk of a household contact becoming infected is low. So it’s time to lift isolation requirements, now so many of us are immune to the virus.
This sort of precision complements health experts’ efforts, helping humans to be more precise and communicate more precisely.
Instead of making the lives of contact tracers easier, analysis shows the expensive technology missed contacts and added to their workload.
Endemic doesn’t mean we drop our guard, surrender to the virus or downgrade the threat the virus poses to individuals and the community.
We’d all like some answers. But uncertainty over how we count COVID cases is complicating the picture. Here’s what to expect in the days and weeks ahead.
A nationwide genomic surveillance system analyzes positive COVID-19 tests to build a picture of which variants are spreading in the population.
Vaccines and medical treatments can only go so far in an unequal society. Facing the ongoing history of racial discrimination and bias in the US would help end the pandemic.
How two Canadian teams of economists and epidemiologists studied COVID-19 from a social science perspective to show that higher national income inequality is associated with worse COVID outcomes.
For a number of reasons, as time goes on vaccines become less effective. So how do researchers calculate how well vaccines are working?
Machine learning algorithms can help public health officials identify areas of high vaccine hesitancy by ZIP code to better target messaging and outreach and counter misinformation.
The risk of getting the coronavirus from a surface is low. But the frequent hand-washing from early in the pandemic is a good thing since most people weren’t washing their hands enough to begin with.
Les contributeurs les plus fréquents
-
Associate Professor, Epidemiology, Deakin University
-
Professor, School of Medicine, University of Connecticut
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Chair in Epidemiology, Deakin University
-
Professor in Mathematical Biology, The University of Melbourne
-
Professor of Epidemiology, Population Interventions Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne
-
Professor and Chair of Epidemiology, University of Michigan
-
Research Assistant Professor of Epidemiology, University of Michigan
-
Professor of Public Health, American University
-
Professor, epidemiological modelling of infectious diseases, UNSW Sydney
-
Ph.D. Student in Microbiology and Immunology, Vanderbilt Vaccine Center, Vanderbilt University
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Ph.D. Candidate in Chemical & Physical Biology, Vanderbilt Vaccine Center, Vanderbilt University
-
Clinical Professor of Medicine, University of California, San Francisco
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
